XLON
NANO
Market cap20mUSD
Dec 05, Last price
8.44GBP
1D
6.84%
1Q
-24.30%
Jan 2017
-81.24%
IPO
-83.39%
Name
Nanoco Group PLC
Chart & Performance
P/E
—
P/S
1.95
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.07%
Rev. gr., 5y
2.02%
Revenues
8m
+40.16%
Net income
-1m
L
CFO
51m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nanoco Group plc, together with its subsidiaries, engages in the research, development, manufacture, and licensing of novel nanomaterials for use in various commercial applications. The company offers CFQD quantum dots consisting of fluorescent semiconductor nanoparticles for OLED and µLED colour conversion, QD-EL, and security tagging applications; HEATWAVE quantum dots to use in the sensor industry; and VIVODOTS nanoparticles for medical and veterinary applications. It has operations in the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. The company was formerly known as Evolutec Group plc and changed its name to Nanoco Group plc in April 2009. Nanoco Group plc was founded in 2001 and is based in Runcorn, the United Kingdom.
IPO date
May 01, 2009
Employees
36
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | 2016‑07 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||